- Case Report
- Open access
- Published:
A challenging coexistence: community-acquired methicillin-resistant Staphylococcus aureus and Mycobacterium tuberculosis
The Egyptian Journal of Bronchology volume 18, Article number: 67 (2024)
Abstract
Background
Community-acquired Methicillin-resistant Staphylococcus aureus (CA-MRSA) usually emerges after a viral infection and causes severe disease in immunocompetent individuals. Concurrent infection with tuberculosis (TB) is generally very rare in immunocompetent patients. Our case is the first report of the coexistence of CA-MRSA and TB in an immunocompetent patient.
Case presentation
A 24-year-old male patient of African origin, who has been living in Turkey for a year, was admitted to our hospital 3 months ago with fever, cough, and sputum complaints, which developed following symptoms of influenza infection. More intense bilateral infiltration and cavitary appearance were observed on the left in the chest radiography of the patient who did not respond to amoxicillin and gemifloxacin treatments. The patient’s sputum culture showed MRSA growth, and his sputum acid-resistant bacteria (ARB) was reported as three positive. Vancomycin, isoniazid, rifampicin, pyrazinamide, and ethambutol treatments were started. Subsequently, Mycobacterium Tuberculosis growth was also detected in the mycobacteria culture. Vancomycin treatment was completed in 14 days. There was no growth in the control sputum culture. When the patient, who gave clinical and laboratory response, was admitted with increased shortness of breath complaint two months after discharge, it was observed that minimal spontaneous pneumothorax developed in the left lung, and it was decided to follow up without intervention. In the second month of tuberculosis treatment, sputum ARB and mycobacteria culture became negative, and the patient was switched to dual antituberculosis treatment (isoniazid, rifampicin), and his treatment is still ongoing.
Conclusions
Mixed infections should be considered in case of non-response to treatment in patients with pneumonia. Mixed infections should also be followed closely as they may be more complicated.
Background
Staphylococcus aureus, a member of the Staphylococcaceae family, is a human pathogen that lives as a commensal in the armpit, pharynx, vagina, perineum, or eroded skin, with a rate of 30–50% in the anterior nasal mucosa [1]. S. aureus has been reported to colonize approximately 30% of the world’s population [2]. Methicillin-resistant S. aureus (MRSA) can be a causative agent in both community-acquired (CA-MRSA) and hospital-acquired pneumonia [3]. The estimated CA-MRSA prevalence is approximately 0.51–0.64 per 100,000. Mortality in CA-MRSA pneumonia is significantly higher than in methicillin-sensitive strains and has been reported as 56–63% [4].
Many cases of CA-MRSA occur after a viral infection. Even in immunocompetent individuals, lung infiltration, necrosis, hemoptysis, and severe sepsis can cause septic embolism [5,6,7]. Concomitant infection with tuberculosis is generally very rare in immunocompetent patients. Our case is the first report of the coexistence of community-acquired MRSA and TB in an immunocompetent patient.
Case presentation
A 24-year-old male patient of African origin, who has been living in Turkey for a year, was admitted to our hospital 3 months ago with symptoms of fatigue, muscle pain, and sore throat, followed by fever, cough, and sputum. More intense bilateral infiltration and cavitary appearance were observed on the left in the chest radiography of the patient who did not respond to amoxicillin and gemifloxacin treatments (Fig. 1a). Sputum acid-resistant bacteria (ARB) results were found to be negative twice. The patient, whose complaints of fever, dyspnea, cough, and sputum continued to increase, was hospitalized and examined. There was no feature other than a fever of 38.2 °C and inspiratory rales in the upper zone of the left lung in physical examination. No BCG scar was observed. It was learned that the patient, who had no comorbidities, did not use medication, cigarettes, alcohol, or drugs and did not have TB. Anti-HIV test was negative. Laboratory tests of the patient were leukocyte 5.5 K/μL (normal 4.5–11 K/μL), lymphocyte: 0.57 K/μL (normal 1.1–5.1 K/μL) (10.4%), neutrophil: 4.61 K/μL (normal 1.8–7.3 K/μL) (83.8%), CRP 171 mg/L (normal 0–5 mg/L), AST 88 U/L (normal 5–34 U/L), ALT 58 U/L (normal 0–55 U/L), and kidney function tests were normal. Vancomycin treatment was started for the patient due to MRSA growth in the sputum culture. When the sputum ARB was sent again, three positives were detected, and the patient was started on isoniazid, rifampicin, pyrazinamide, and ethambutol treatment. Mycobacterium tuberculosis was also detected in the mycobacterial culture in the follow-up. Anti-tuberculosis drug resistance test was negative. Vancomycin treatment was completed in 14 days. There was no bacterial growth in the control sputum culture. The patient received clinical and laboratory responses and was discharged. After two months, the patient was admitted with complaints of increased dyspnea and a new spontaneous pneumothorax on the left was observed on chest radiography (Fig. 1b). Thorax computed tomography (CT) showed bilateral infiltration, necrotic parenchyma, and minimal pneumothorax on the left (Fig. 2). Since the patient’s clinical condition was stable, it was decided to follow up without intervention. In the 2nd month of tuberculosis treatment, sputum ARB and mycobacteria culture became negative, drug resistance test was also negative dual antituberculosis treatment (isoniazid, rifampicin) was started and treatment is still ongoing.
Discussion
Whether or not pneumonia develops is determined by the host’s immune response, the virulence of the infecting organism, and the presence of vaccination. Comorbidities such as impaired cough reflex and mucociliary clearance, impaired local and humoral immunity, alcohol use and smoking, chronic obstructive pulmonary disease (COPD), congestive heart failure, chronic kidney disease, liver disease, and immunodeficiency conditions constitute a predisposition for the development of community-acquired pneumonia. CA-MRSA pneumonia, on the other hand, usually occurs after influenza infection in patients who have not previously been exposed to any health care [8]. Influenza can weaken T cell immunity and innate immune responses to secondary bacterial infections [9]. Thus, it can also pave the way for the reactivation of latent tuberculosis. In our case, both CA-MRSA and Mycobacterium tuberculosis were found to be the causative agent of pneumonia that developed following flu-like symptoms. We aimed to contribute to the literature by reporting this association in an immunocompetent patient for the first time.
The Centers for Disease Control and Prevention (CDC) definition of CA-MRSA infection includes the presence of a positive MRSA culture isolated within 48 h of admission, absence of indwelling catheters or medical devices permanently implanted in the skin, absence of a history of prior MRSA colonization and absence of a recent history of significant hospitalization [10]. Our case also meets these criteria.
The burden from staphylococcal infections in Africa is overshadowed by the common diseases HIV/AIDS, tuberculosis, and malaria [11]. Surveillance studies of bacterial infections in Africa indicate that S. aureus is a common pathogen in healthy adults immunocompromised individuals, and those with a genetic predisposition [12]. It has also been reported that MRSA prevalence can rise to 78.6% in African countries [13]. The fact that our patient was of African origin suggests that the possibility of being colonized with MRSA is high.
CA-MRSA pneumonia should be considered in the differential diagnosis, especially in healthy young individuals with rapidly progressive clinical features, including cavitary consolidation, bilateral infiltration, pleural effusion, and hemoptysis [14]. In patients with severe disease, MRSA can cause lung necrosis by producing various exotoxins, including Panton-Valentine leukocidin [15]. Panton-Valentine leukocidin toxin could not be tested in our case. We also think that in our case, accompanying TB also increased the necrotic/cavitary appearance in the lung.
Although parapneumonic effusion, empyema, necrotizing pneumonia, pneumothorax, and lung abscess are more common as acute complications of bacterial pneumonia [16], pneumothorax may also develop. Spontaneous pneumothorax is caused by visceral pleural tear resulting from subpleural bleb or necrotic parenchymal process or hyperinflation of distal airways due to dynamic bronchiole obstruction resulting in check-valve and subsequent alveolar rupture [17]. Secondary spontaneous pneumothorax occurs due to an underlying lung disorder and, therefore, has a worse prognosis than primary spontaneous pneumothorax [18]. Pneumothorax developing in severe CA-MRSA pneumonia may develop secondary to barotrauma and underlying lung necrosis in intubated patients [19]. In some series, it has been reported that pneumothorax develops in 60% of patients with severe CA-MRSA pneumonia [20]. Spontaneous pneumothorax secondary to pulmonary TB may develop in rare cases of residual fibrosis with retractions and bullae [21]. The frequency of spontaneous pneumothorax in active pulmonary TB is approximately 1–2% [22]. In our case, the coexistence of both MRSA and TB may have led to the development of pneumothorax.
Multidrug resistance has been reported in CA-MRSA strains, but in general, these organisms are more drug-sensitive than similar hospital-acquired infections [23]. In our case, there was no multidrug resistance, and there was a response to treatment with Vancomycin.
Conclusion
Mixed infections should be considered in patients being followed up with a diagnosis of pneumonia, especially in cases where there is no response to treatment. Mixed infections also require close follow-up as they may be more complicated.
Availability of data and materials
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
Abbreviations
- CA-MRSA:
-
Community-acquired Methicillin-resistant Staphylococcus aureus
- TB:
-
Tuberculosis
- ARB:
-
Acid-resistant bacteria
- CRP:
-
C-reactive protein
- AST:
-
Aspartate aminotransferase
- ALT:
-
Alanine aminotransferase
- CT:
-
Computed tomography
- COPD:
-
Chronic obstructive pulmonary disease
References
Casewell MW (1998) The nose: an underestimated source of Staphylococcus aureus causing wound infection. J Hosp Infect Sep;40 Suppl B:S3-11. https://doi.org/10.1016/s0195-6701(98)90199-2
CDC T.Staphylococcus aureus infection (2019). https://www.cdc.gov/vitalsign. Accessed 1 Jan 2022.
Kaibni MH, Farraj MA, Adwan K et al (2009) Community-acquired meticillin-resistant Staphylococcus aureus in Palestine. J Med Microbiol 58(Pt 5):644–647. https://doi.org/10.1099/jmm.0.007617-0
Xia H, Gao J, Xiu M et al (2020) Community-acquired pneumonia caused by methicillin-resistant Staphylococcus aureus in a Chinese adult: a case report. Medicine (Baltimore) 99(26):e20914. https://doi.org/10.1097/MD.0000000000020914
Yonezawa R, Kuwana T, Kawamura K et al (2015) Invasive community-acquired methicillin-resistant Staphylococcus aureus in a Japanese girl with disseminating multiple organ ınfection: a case report and review of Japanese pediatric cases. Case Rep Pediatr 2015:291025. https://doi.org/10.1155/2015/291025
Agustin M, Yamamoto M, Tongma C et al (2020) Spontaneous chylothorax following septic pulmonary embolization. Case Rep Pulmonol 21(2020):3979507. https://doi.org/10.1155/2020/3979507
Nair GB, Niederman MS (2011) Community-acquired pneumonia: an unfinished battle. Med Clin North Am 95(6):1143–1161. https://doi.org/10.1016/j.mcna.2011.08.007
Lobo LJ, Reed KD, Wunderink RG (2010) Expanded clinical presentation of community-acquired methicillin-resistant Staphylococcus aureus pneumonia. Chest 138(1):130–136. https://doi.org/10.1378/chest.09-1562
Walaza S, Cohen C, Tempia S et al (2020) Influenza and tuberculosis co-infection: A systematic review. Influenza Other Respir Viruses 14(1):77–91. https://doi.org/10.1111/irv.12670
Sowash MG, Uhlemann AC (2014) Community-associated methicillin-resistant Staphylococcus aureus case studies. Methods Mol Biol 1085:25–69. https://doi.org/10.1007/978-1-62703-664-1_2
Kateete DP, Bwanga F, Seni J et al (2019) CA-MRSA and HA-MRSA coexist in community and hospital settings in Uganda. Antimicrob Resist Infect Control 3(8):94. https://doi.org/10.1186/s13756-019-0551-1
Kizito ME, Mworozi E, Ndugwa C et al (2007) Bacteraemia in homozygous sickle cell disease in Africa: is pneumococcal prophylaxis justified? Arch Dis Child 92(1):21–23. https://doi.org/10.1136/adc.2005.088807
Foloum AK, Founou LL, Karang S et al (2021) Methicillin resistant staphylococci isolated in clinical samples: a 3-year retrospective study analysis. Future Sci OA 7(4):FSO681. https://doi.org/10.2144/fsoa-2020-0183
Gillet Y, Issartel B, Vanhems P et al (2002) Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 359(9308):753–759. https://doi.org/10.1016/S0140-6736(02)07877-7
Francis JS, Doherty MC, Lopatin U et al (2005) Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis 40(1):100–107. https://doi.org/10.1086/427148
Mani CS. Acute pneumonia and its complications. Principles and practice of pediatric infectious diseases, 2018, 238–249.e4.
Wait MA, Estrera A (1992) Changing clinical spectrum of spontaneous pneumothorax. Am J Surg 164(5):528–531. https://doi.org/10.1016/s0002-9610(05)81194-8
Fraser RS, Muller NL, Colman N et al (1999) Fraser and Pare’s diagnosis of diseases of the chest, 4th edn. W.B. Saunders Co., Philadelphia, pp 2784–2794
Stroud MH, Okhuysen-Cawley R, Jaquiss R et al (2007) Successful use of extracorporeal membrane oxygenation in severe necrotizing pneumonia caused by Staphylococcus aureus. Pediatr Crit Care Med 8(3):282–287. https://doi.org/10.1097/01.PCC.0000262795.11598.56
He H, Wang H, Li X et al (2017) Successful rescue combination of extracorporeal membrane oxygenation, high-frequency oscillatory ventilation and prone positioning for the management of severe methicillin-resistant Staphylococcus aureus pneumonia complicated by pneumothorax: a case report and literature review. BMC Pulm Med 17(1):103. https://doi.org/10.1186/s12890-017-0445-z
Briones-Claudett KH, Briones-Claudett MH, Posligua Moreno A et al (2020Mar) Spontaneous pneumothorax after rupture of the cavity as the ınitial presentation of tuberculosis in the emergency department. Am J Case Rep 20(21):e920393. https://doi.org/10.12659/AJCR.920393
Belmonte R, Crowe HM (1995) Pneumothorax in patients with pulmonary tuberculosis. Clin Infect Dis 20(6):1565. https://doi.org/10.1093/clinids/20.6.1565
Diep BA, Chambers HF, Graber CJ et al (2008) Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men. Ann Intern Med 148(4):249–257. https://doi.org/10.7326/0003-4819-148-4-200802190-00204
Acknowledgements
Not applicable.
Funding
The study received no external funding.
Author information
Authors and Affiliations
Contributions
EA wrote the initial draft of the manuscript. AS and AEG managed the diagnosis and treatment. EA, AS, and AEG approved the final version of the manuscript and agreed to be accountable for all aspects of the work. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
Written and verbal informed consent was obtained from the patient for publication of this case report.
Consent for publication
Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.
Competing interests
The authors declare that they have no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Afşin, E., Sümbül, A. & Gülözer, A.E. A challenging coexistence: community-acquired methicillin-resistant Staphylococcus aureus and Mycobacterium tuberculosis. Egypt J Bronchol 18, 67 (2024). https://doi.org/10.1186/s43168-024-00319-5
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s43168-024-00319-5